Shailaja Kalyankrishna

1.7k citations
9 papers · 1.3k indexed · 1 hit paper · h-index 9
Topics
HER2/EGFR in Cancer Research (4 papers)Lung Cancer Treatments and Mutations (4 papers)Peptidase Inhibition and Analysis (3 papers)
Partner nations
United StatesJapanFrance

In The Last Decade

Shailaja Kalyankrishna

9 papers receiving 1.3k citations

Hit Papers

Epidermal Growth Factor Receptor Biology in Head and Neck...20062026201220192006100200300400500

Peers

Shailaja Kalyankrishna
Comparison fields: 5 of 88
  • Oncology 708
  • Molecular Biology 694
  • Pulmonary and Respiratory Medicine 578
  • Cancer Research 185
  • Otorhinolaryngology 155
Replace Luka Milas with:
Luka Milas United States
Justine Y. Bruce United States
Miguel Quintela-Fandiño Spain
Annett Linge Germany
Neil E. Bhola United States
Rosa Caputo Italy
Alice Banh United States
Dai Nakashima Japan
Elena A. Takano Australia
Babita Saigal United States
Shailaja Kalyankrishna relative to Luka Milas United States Luka Milas's profile →
Citations per field
00.5×5.7×
Luka Milas · 1×
Citations per year

Countries citing papers authored by Shailaja Kalyankrishna

Since Specialization
Citations

This map shows the geographic impact of Shailaja Kalyankrishna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shailaja Kalyankrishna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shailaja Kalyankrishna more than expected).

Fields of papers citing papers by Shailaja Kalyankrishna

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shailaja Kalyankrishna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shailaja Kalyankrishna. The network helps show where Shailaja Kalyankrishna may publish in the future.

Co-authorship network of co-authors of Shailaja Kalyankrishna

This figure shows the co-authorship network connecting the top 25 collaborators of Shailaja Kalyankrishna. A scholar is included among the top collaborators of Shailaja Kalyankrishna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shailaja Kalyankrishna. Shailaja Kalyankrishna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1 30
2 130
3
Epidermal Growth Factor Receptor Biology in Head and Neck Cancerbreakdown →
558
4 54
5 10
6 125
7 357
8 49
9 23

About Shailaja Kalyankrishna

Shailaja Kalyankrishna is a scholar working on Oncology, Biochemistry and Biochemistry, having authored 9 papers that have together received 1.3k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Peptidase Inhibition and Analysis (3 papers). The work is most often cited by research in Otorhinolaryngology (155 citations), Oncology (708 citations) and Pulmonary and Respiratory Medicine (578 citations). Shailaja Kalyankrishna has collaborated with scholars based in United States, Japan and France. Frequent co-authors include Jennifer R. Grandis, Jonathan M. Kurie, Kafait U. Malik, John D. Minna, Michael Peyton, Denise M. Juroske, Joyce E. Ohm, Kiyoshi Yanagisawa, Hisayuki Shigematsu and David P. Carbone. Their work appears in journals such as Journal of Clinical Oncology, Molecular and Cellular Biology and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026